The page lists 35 projects related to the topic "arrhythmia".
# | |||
---|---|---|---|
1 | CATCH ME | Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly | 2015 |
2 | MODELAGE | Is your heart aging well? A systems biology approach to characterize cardiac aging from the cell to the body surface | 2015 |
3 | WASTCArD | Wrist and arm sensing technologies for cardiac arrhythmias detection | 2015 |
4 | AFIBROTIC | Atrial Fibrillation, Fibrosis and Rotors: New Insights from Imaging and Computational Modeling | 2015 |
5 | RISTRAD | Risk Stratification for Sudden Cardiac Death | 2015 |
6 | AFib-TrainNet | EU Training Network on Novel Targets and Methods in Atrial Fibrillation | 2015 |
7 | STEMCARDIORISK | Stem Cells for Cardiac Arrhythmia Risk Assessment | 2015 |
8 | CellStretch | A Cardiomyocyte Workout:Using Dielectric Elastomer Actuators for Mechanical Stimulation of in-vitro Cells | 2016 |
9 | HeartAtaK | Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel | 2016 |
10 | Nyxoah | Ultra-small implanted neurostimulation device for the treatment of Obstructive Sleep Apnea | 2016 |
11 | isitFlutter | dIagnoSIs app for regular aTrial arrhytmia like Flutter | 2016 |
12 | CResPace | Adaptive Bio-electronics for Chronic Cardiorespiratory Disease | 2017 |
13 | Bio-ICD | Biological auto-detection and termination of heart rhythm disturbances | 2017 |
14 | LifeCall | LifeCall Wearable EKG Heart Health Monitoring, Analysing and Warning System | 2018 |
15 | iPS-ChOp-AF | Combining induced pluripotent stem cells, tissue engineering, optogenetic and chemogenetic concepts for the study and treatment of atrial fibrillation | 2018 |
16 | PREMEDiCARE | PREcision MEDicine with induced pluripotent stem cells for Cardiac Arrhythmias Risk Evaluation | 2018 |
17 | COSMOS | COSMOS: Computational Shaping and Modeling of Musical Structures | 2019 |
18 | AuriGen | Next Generation Left Atrial Appendage Implant to Treat Persistent Atrial Fibrillation | 2018 |
19 | RedStroke | Smart ICT-solution to cost-efficiently detect atrial fibrillation to Reduce Europe’s burden of Stroke | 2018 |
20 | p38_InTh | Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity | 2018 |
21 | CARDIACSENSE | A new clinically proven and reliable medical solution for continuous heart arrhythmia and blood pressure monitoring | 2018 |
22 | LAA-START | Left Atrial Appendage Electrical Isolation via Bio-photonic Optical Confirmation to Treat Persistent Atrial Fibrillation | 2019 |
23 | Rithmi | RITHMI: THE SMART MONITOR THAT TAKES CARE OF YOUR HEART | 2018 |
24 | HepEDOT | Conductive, self-doping and biodegradable oligoEDOT-heparin biomaterial for improved electromechanical coupling, cardiac cell retention and delivery of paracrine factors | 2019 |
25 | INFLOW | Finding Flow: Negotiating diverse temporalities in migrant family life | 2020 |
26 | ViaOne | A MINIMALLY INVASIVE NEEDLE FREE DEVICE TO SAFELY ACCESS THE PERICARDIUM SPACE | 2019 |
27 | ABLAVIEW | An Innovative Image Guided Radiofrequency Ablation System to treat Atrial Fibrillation | 2019 |
28 | MrDoc | Development and commercialization of a semi-supervised learning AI for robust diagnosis in real world settings. | 2019 |
29 | Cardio-kit | A disruptive medical device to enable proton therapy as non-invasive and automated treatment of heart arrhythmias | 2019 |
30 | IPUD | An Implantable Peritoneal Ultrafiltration Device that actively and continuously prevents fluid overload in congestive heart failure patients | 2019 |
31 | PersonalizeAF | Personalized Therapies for Atrial Fibrillation. A Translational Approach | 2020 |
32 | SN-marker | Secretoneurin (SN): the first blood biomarker to accurately stratify mortality risk in patients with cardiac arrhythmia | 2019 |
33 | MOLEC ANTI-ARRHYT | Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design | 2020 |
34 | Neuron-AFib | Commercialising cardiac autonomic modulation to treat Atrial Fibrillation | 2019 |
35 | AFFECT-EU | DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY | 2020 |